Lv1
10 积分 2023-10-22 加入
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation
2天前
已完结
Outcomes for Hyperthermia Combined with Concurrent Radiochemotherapy for Patients with Cervical Cancer
9个月前
已完结
Microglia drive transient insult-induced brain injury by chemotactic recruitment of CD8+ T lymphocytes
1年前
已完结
Microglia drive transient insult-induced brain injury by chemotactic recruitment of CD8+ T lymphocytes
1年前
已完结
皖公网安备34019202002308
